PolyU and HOYA Launch Revolutionary Myopia Control Lens Proven Effective for Children Aged 4+
HK01 · 1 SOURCESabout 1 hour ago2 MIN
Summary
HOYA and Hong Kong Polytechnic University (PolyU) have jointly developed the MiYOSMART iQ, a pioneering myopia control lens featuring the Triple Enhanced Design (DIMS TED) technology. Clinical trials conducted over 12 months with 196 Hong Kong children aged 4-12 demonstrated that young users experienced effectively halted myopia progression. This breakthrough extends myopia management down to children as young as 4 years old, addressing Hong Kong's status as one of the global capitals of childhood myopia.
Key Points
- Hong Kong ranks among the world's highest for myopia prevalence, with approximately 8 in 10 young adults aged 18 affected
- The MiYOSMART iQ lens employs D.I.M.S. Technology with Triple Enhanced Design (DIMS TED), featuring a reduced central optical zone, enhanced defocus power, and extended peripheral treatment area
- The 12-month double-blind, placebo-controlled, randomized clinical trial enrolled 196 eligible myopic children aged 4-12, randomly assigned in 1:1:1 ratio across three lens groups
- Average results showed DIMS TED group experienced no clinically significant myopia progression over 12 months, with effective slowing of excessive axial elongation
- An 8-year-old girl (Hui Yat-yan) who switched from single-vision lenses to MiYOSMART iQ reduced her yearly myopia progression from 100 degrees to just 50 degrees in both eyes
- A 14-year-old boy (Kwan Tsz-king) achieved actual myopia regression, with his right eye improving by 25 degrees and left eye by 75 degrees after two years of use
- OPTICAL 88 x HOYA Children's Myopia Management Center is located at Shop 605, Level 6, New Town Plaza Phase 1, Sha Tin, New Territories
Why It Matters
Hong Kong's escalating childhood myopia crisis poses serious long-term health risks, including heightened vulnerability to glaucoma, cataracts, macular degeneration, and retinal detachment. The MiYOSMART iQ provides parents with a safe, convenient, and non-invasive tool to protect their children's vision from as young as age 4, potentially preventing the cascade of complications associated with high myopia later in life .
Hong Kong's escalating childhood myopia crisis poses serious long-term health risks, including heightened vulnerability to glaucoma, cataracts, macular degeneration, and retinal detachment. The MiYOSMART iQ provides parents with a safe, convenient, and non-invasive tool to protect their children's vision from as young as age 4, potentially preventing the cascade of complications associated with high myopia later in life .